- CSR Summary Not Yet Available
- Primary Citation Trial has yet to be published
You are not logged in.
Please login to continue selecting trials.
Generic NameDaratumumabProduct NameDARZALEX®Therapeutic AreaCancers and Other NeoplasmsEnrollment242% FemaleN/A% WhiteN/A
Product ClassMonoclonal AntibodySponsor Protocol Number54767414MMY1001Data PartnerJohnson & JohnsonCondition StudiedMultiple MyelomaMean/Median Age (Years)N/A
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available